These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9744720)
1. Effects of vinorelbine and titanocene dichloride on human tumour xenografts in nude mice. Friedrich M; Villena-Heinsen C; Farnhammer C; Schmidt W Eur J Gynaecol Oncol; 1998; 19(4):333-7. PubMed ID: 9744720 [TBL] [Abstract][Full Text] [Related]
2. Human ovarian cancer xenografts in nude mice: chemotherapy trials with paclitaxel, cisplatin, vinorelbine and titanocene dichloride. Villena-Heinsen C; Friedrich M; Ertan AK; Farnhammer C; Schmidt W Anticancer Drugs; 1998 Jul; 9(6):557-63. PubMed ID: 9877245 [TBL] [Abstract][Full Text] [Related]
3. Relationship between chemotherapy with paclitaxel, cisplatin, vinorelbine and titanocene dichloride and expression of proliferation markers and tumour suppressor gene p53 in human ovarian cancer xenografts in nude mice. Kolberg HC; Villena-Heinsen C; Deml MM; Kraemer S; Diedrich K; Friedrich M Eur J Gynaecol Oncol; 2005; 26(4):398-402. PubMed ID: 16122187 [TBL] [Abstract][Full Text] [Related]
4. Human tumour xenografts in nude mice: chemotherapy trials with titanocene dichloride in different dosages. Villena-Heinsen C; Friedrich M; Ertan AK; Schmidt W Clin Exp Obstet Gynecol; 1998; 25(1-2):5-8. PubMed ID: 9743868 [TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma. Köpf-Maier P Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588 [TBL] [Abstract][Full Text] [Related]
6. Anti-proliferative activity and mechanism of action of titanocene dichloride. Christodoulou CV; Eliopoulos AG; Young LS; Hodgkins L; Ferry DR; Kerr DJ Br J Cancer; 1998 Jun; 77(12):2088-97. PubMed ID: 9649119 [TBL] [Abstract][Full Text] [Related]
7. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour. Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106 [TBL] [Abstract][Full Text] [Related]
8. Anti-tumor activity of Titanocene Y in xenografted Caki-1 tumors in mice. Fichtner I; Pampillón C; Sweeney NJ; Strohfeldt K; Tacke M Anticancer Drugs; 2006 Mar; 17(3):333-6. PubMed ID: 16520662 [TBL] [Abstract][Full Text] [Related]
9. Biological and pharmacological characterisation of three models of human ovarian carcinoma established in nude mice: use of the CA125 tumour marker to predict antitumour activity. Burbridge MF; Kraus-Berthier L; Naze M; Pierre A; Atassi G; Guilbaud N Int J Oncol; 1999 Dec; 15(6):1155-62. PubMed ID: 10568822 [TBL] [Abstract][Full Text] [Related]
10. A proposed mechanism for the inhibitory effect of the anticancer agent titanocene dichloride on tumour gelatinases and other proteolytic enzymes. Pavlaki M; Debeli K; Triantaphyllidou IE; Klouras N; Giannopoulou E; Aletras AJ J Biol Inorg Chem; 2009 Aug; 14(6):947-57. PubMed ID: 19390879 [TBL] [Abstract][Full Text] [Related]
11. Tumor inhibition by titanocene complexes: influence upon two xenografted human lung carcinomas. Köpf-Maier P J Cancer Res Clin Oncol; 1987; 113(4):342-8. PubMed ID: 3036884 [TBL] [Abstract][Full Text] [Related]
12. Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer. Aravantinos G; Bafaloukos D; Fountzilas G; Christodoulou C; Papadimitriou C; Pavlidis N; Kalofonos HP; Gogas H; Kosmidis P; Dimopoulos MA Ann Oncol; 2003 Jul; 14(7):1094-9. PubMed ID: 12853352 [TBL] [Abstract][Full Text] [Related]
13. A Monte Carlo evaluation of dose enhancement by cisplatin and titanocene dichloride chemotherapy drugs in brachytherapy with photon emitting sources. Yahya Abadi A; Ghorbani M; Mowlavi AA; Knaup C Australas Phys Eng Sci Med; 2014 Jun; 37(2):327-36. PubMed ID: 24706342 [TBL] [Abstract][Full Text] [Related]
14. Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells. O'Connor K; Gill C; Tacke M; Rehmann FJ; Strohfeldt K; Sweeney N; Fitzpatrick JM; Watson RW Apoptosis; 2006 Jul; 11(7):1205-14. PubMed ID: 16699961 [TBL] [Abstract][Full Text] [Related]
15. Vinorelbine: a new promising drug in Hodgkin's disease. Devizzi L; Santoro A; Bonfante V; Viviani S; Bonadonna G Leuk Lymphoma; 1996 Aug; 22(5-6):409-14. PubMed ID: 8882953 [TBL] [Abstract][Full Text] [Related]
16. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents. Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549 [TBL] [Abstract][Full Text] [Related]
17. The current and future place of vinorelbine in cancer therapy. Cvitkovic E; Izzo J Drugs; 1992; 44 Suppl 4():36-45; discussion 66-9. PubMed ID: 1283849 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivatives. Moebus VJ; Stein R; Kieback DG; Runnebaum IB; Sass G; Kreienberg R Anticancer Res; 1997; 17(2A):815-21. PubMed ID: 9137413 [TBL] [Abstract][Full Text] [Related]
19. A controlled release system of titanocene dichloride by electrospun fiber and its antitumor activity in vitro. Chen P; Wu QS; Ding YP; Chu M; Huang ZM; Hu W Eur J Pharm Biopharm; 2010 Nov; 76(3):413-20. PubMed ID: 20854905 [TBL] [Abstract][Full Text] [Related]
20. Antitumor metallocenes: new developments and toxicologic features. Köpf-Maier P; Köpf H Anticancer Res; 1986; 6(2):227-33. PubMed ID: 3707060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]